|
Session 158
Poster Abstracts
Vaccination against Hepatitis A or B Viruses in HIV-Infected Persons
Monday, 1 - 4 pm
Poster Hall |
883
 |
The Efficacy of High-dose Recombinant Hepatitis B Vaccination in HIV-infected Patients Who Failed at First Series of Vaccinations
T.E.M.S. de Vries-Sluijs*, B Hansen, G van Doornum, T Springeling, N Evertsz, R de Man, and M van der Ende
Erasmus Med Ctr, Rotterdam, The Netherlands |
| 884 |
Strategies for Management and Optimization of Response to Hepatitis B Vaccination in HIV Patients
S Low, A Prior, B Mooka, S Clarke, Fiona Mulcahy*, and C Bergin
St James's Hosp, Dublin, Ireland |
885
|
Randomized Trial Comparing a 3-Dose Regimen to a Standard 2- Dose Regimen of Hepatitis A Vaccine in HIV-infected Adult Patients with CD4+ T Cells between 200 and 500 per mm3 (HEPAVAC Study)
Odile Launay*1, S Grabar1, E Gordien2, C Desaint1, J Dimet1, D Jegou1, P M Girard3, D Salmon1, S Abad2, D Rey4, and HEPAVAC Study Group
1Hosp Cochin, Paris, France; 2Hosp Avicenne, Bobigny, France; 3Hosp St Antoine, Paris, France; and 4Univ Hosp Strasbourg, France |
|
